FDA approves Cephalon's REMS for GABITRIL
Links shared publicly online about this topic.
- 800total visits
FDA approves Cephalon's REMS for GABITRIL
View full resource at news-medical.net
Tags: Seizure, Epilepsy, Diet and Nutrition, Drug, FDA, Cephalon, News
Most Recently Shared on October 15, 2010 at 9:13 am By:
Epilepsy News: FDA approves Cephalon's REMS for GABITRIL: Cephalon, Inc. today announced that a Risk Evaluation an... http://bit.ly/c5l1ZP
FDA approves REMS for Fentora, Actiq | Oral Cancer News
oralcancernews.org — “FDA approves REMS for Fentora, Actiq | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on July 25, 2011 at 10:44 am By:
REMS approved for Nuvigil and Provigil - MPR
empr.com — “Cephalon announced that the FDA has approved Risk Evaluation and Mitigation Strategies (REMS) for its medications Nuvigil (armodafinil tablets) and Provigil (modafinil tablets).” View full resource at empr.com
Most Recently Shared on October 25, 2010 at 3:23 pm By:
MPR News: REMS approved for Nuvigil and Provigil: Cephalon announced that the FDA has approved Risk Evaluation and... http://bit.ly/b6GMSc
REMS approved for Nuvigil and Provigil - ONA
oncologynurseadvisor.com — “Cephalon announced that the FDA has approved Risk Evaluation and Mitigation Strategies (REMS) for its medications Nuvigil (armodafinil tablets) and Provigil (modafinil tablets).” View full resource at oncologynurseadvisor.com
Most Recently Shared on October 25, 2010 at 3:07 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
REMS approved for Nuvigil and Provigil http://goo.gl/fb/vJcSS
FDA approves REMS for Gabitril - MPR
empr.com — “The FDA has approved a Risk Evaluation and Mitigation Strategy (REMS) for the antiepileptic drug (AED) Gabitril (tiagabine hydrochloride, from Cephalon).” View full resource at empr.com
Most Recently Shared on October 15, 2010 at 2:06 pm By:
MPR News: FDA approves REMS for Gabitril: The FDA has approved a Risk Evaluation and Mitigation Strategy (REMS) fo... http://bit.ly/bz7JDu
Cephalon Gabitril REMS gets FDA approval - Pharmaceutical Business Review
packaging.pharmaceutical-business-review.com — “Cephalon said that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication Gabitril (tiagabine hydrochloride) has been appro” View full resource at packaging.pharmaceutical-business-review.com
Most Recently Shared on October 15, 2010 at 6:49 am By:
Cephalon Gabitril REMS gets FDA approval http://goo.gl/bMIE #pharmaceutical #news
Advertisement
